The transfer of MDSCs from Tff2-null mice resulted in a marked (10-fold) stimulation of tumour growth in CD2–Tff2 mice (Fig. 3c,d), converting the tumour-resistant CD2–Tff2 mice into a tumour susceptible phenotype. This evidence concerns the gene TFF2 and neoplasm.